US 10259846
Bouvardin derivatives and therapeutic uses thereof
granted A61KA61K31/704A61K38/00
Quick answer
US patent 10259846 (Bouvardin derivatives and therapeutic uses thereof) held by The Regents of the University of Colorado expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado
- Grant date
- Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/704, A61K38/00, A61K38/12, A61K45/06